June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Clinical utility of Spectral-Domain Optical Coherence Tomography (SD-OCT) marker Disorganization of Retinal Inner Layers (DRIL) in Diabetic Retinopathy (DR)
Author Affiliations & Notes
  • Srinidhi Singuri
    Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio, United States
  • Shiming Luo
    Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio, United States
  • Dilara Hatipoglu
    Case Western Reserve University, Cleveland, Ohio, United States
  • Amy Nowacki
    Cleveland Clinic, Cleveland, Ohio, United States
  • Riya Patel
    Case Western Reserve University, Cleveland, Ohio, United States
  • Andrew Schachat
    Cleveland Clinic Cole Eye Institute, Cleveland, Ohio, United States
  • Aleksandra V Rachitskaya
    Cleveland Clinic Cole Eye Institute, Cleveland, Ohio, United States
  • Justis P Ehlers
    Cleveland Clinic Cole Eye Institute, Cleveland, Ohio, United States
  • Sumit Sharma
    Cleveland Clinic Cole Eye Institute, Cleveland, Ohio, United States
  • Peter K Kaiser
    Cleveland Clinic Cole Eye Institute, Cleveland, Ohio, United States
  • Sunil K Srivastava
    Cleveland Clinic Cole Eye Institute, Cleveland, Ohio, United States
  • Elias I Traboulsi
    Cleveland Clinic Cole Eye Institute, Cleveland, Ohio, United States
  • Daniel F Martin
    Cleveland Clinic Cole Eye Institute, Cleveland, Ohio, United States
  • Rishi P Singh
    Cleveland Clinic Cole Eye Institute, Cleveland, Ohio, United States
  • Bela Anand-Apte
    Cleveland Clinic Cole Eye Institute, Cleveland, Ohio, United States
  • Alex Yuan
    Cleveland Clinic Cole Eye Institute, Cleveland, Ohio, United States
  • Footnotes
    Commercial Relationships   Srinidhi Singuri None; Shiming Luo None; Dilara Hatipoglu None; Amy Nowacki None; Riya Patel None; Andrew Schachat None; Aleksandra Rachitskaya Alcon, Code C (Consultant/Contractor), Allergan, Code C (Consultant/Contractor), Novartis, Code C (Consultant/Contractor), Zeiss, Code C (Consultant/Contractor), Genentech, Code C (Consultant/Contractor), Regeneron, Code C (Consultant/Contractor), Samsara, Code C (Consultant/Contractor); Justis Ehlers Aerpio, Code C (Consultant/Contractor), Allergan, Code C (Consultant/Contractor), Genentech, Code F (Financial Support), Alcon, Code F (Financial Support), Boehringer-Ingelheim, Code F (Financial Support), Allegro, Code F (Financial Support), Allergan, Code F (Financial Support), Leica, Code P (Patent); Sumit Sharma None; Peter Kaiser None; Sunil Srivastava Abbvie, Code C (Consultant/Contractor), Novartis, Code C (Consultant/Contractor), Allergan, Code F (Financial Support), Eyepoint, Code F (Financial Support), Eyevensys, Code F (Financial Support), Regeneron, Code F (Financial Support), Santen, Code F (Financial Support), Leica, Code P (Patent); Elias Traboulsi None; Daniel Martin None; Rishi Singh Bausch and Lomb, Code C (Consultant/Contractor), Genentech, Code C (Consultant/Contractor), Novartis, Code C (Consultant/Contractor), Regeneron, Code C (Consultant/Contractor), Zeiss, Code C (Consultant/Contractor), Aerie, Code F (Financial Support), Apellis, Code F (Financial Support), Graybug, Code F (Financial Support); Bela Anand-Apte None; Alex Yuan None
  • Footnotes
    Support  Research to Prevent Blindness (RPB) Medical Student Fellowship
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 2517 – F0243. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Srinidhi Singuri, Shiming Luo, Dilara Hatipoglu, Amy Nowacki, Riya Patel, Andrew Schachat, Aleksandra V Rachitskaya, Justis P Ehlers, Sumit Sharma, Peter K Kaiser, Sunil K Srivastava, Elias I Traboulsi, Daniel F Martin, Rishi P Singh, Bela Anand-Apte, Alex Yuan; Clinical utility of Spectral-Domain Optical Coherence Tomography (SD-OCT) marker Disorganization of Retinal Inner Layers (DRIL) in Diabetic Retinopathy (DR). Invest. Ophthalmol. Vis. Sci. 2022;63(7):2517 – F0243.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Diabetic retinopathy (DR) is a vision-threatening microvascular complication that affects one-third of all diabetics. Fundus examination and imaging, commonly spectral domain optical coherence tomography (SD-OCT), are used to screen for, diagnose and monitor complications of DR. Disorganization of retinal inner layers (DRIL) is an understudied SD-OCT parameter. To investigate the clinical utility of DRIL in DR, we evaluate its relationship with several DR risk and progression factors.

Methods : A retrospective cohort study was conducted at a large academic center following Institutional Review Board approval. The cohort comprised 1,175 randomly selected, non-consecutive patients with ICD-9/10 codes for type 2 diabetes with and without retinopathy between September 2009 and January 2019 (n=2,083 eyes). Demographics, anti-hyperglycemic history, hemoglobin A1c (HbA1c), and VA were obtained by electronic medical record review. SD-OCT scans were evaluated for DRIL by two trained, double-blinded graders. Disagreement was arbitrated by a third blinded grader. Interrater reliability was tested with a kappa statistic. Generalized estimating equation logistic regression models were used to evaluate relationships between variables.

Results : Of 2,083 eyes, 28.08% (n=585) demonstrate presence of DRIL with high interrater reliability (K=0.88, 95% confidence interval (CI) [0.86-0.90]). Insulin users have more severe DR (p<.0001). DRIL is associated with worse VA (p<.001) and DR severity (p<.0001). Unadjusted, insulin usage appears to be associated with DRIL (OR 1.91, 95% CI [1.49-2.45]), however after accounting for DR severity, we find that DRIL is not associated with insulin usage (p=0.25). The remaining DR-related factors (other anti-hyperglycemic usage, HbA1c, sex, race and age) are not associated with DRIL.

Conclusions : DRIL is a promising clinical parameter in patients with DR. SD-OCT marker DRIL is strongly associated with severity of DR and worse VA, supporting its utility as an unfavorable prognostic predictor. Initially, DRIL appeared strongly associated with insulin use, however after adjusting for DR severity, DRIL is not associated with insulin use. Thus, DR severity confounds the relationship between DRIL and insulin use.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

 

Figure 1. Distribution of Visual Acuity by DRIL Status.

Figure 1. Distribution of Visual Acuity by DRIL Status.

 

Table 1. Multivariable Model Evaluating Associations with DRIL.

Table 1. Multivariable Model Evaluating Associations with DRIL.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×